Achieve Life Sciences
ACHV
29 hedge funds and large institutions have $14.9M invested in Achieve Life Sciences in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 7 closing their positions.
695% more call options, than puts
Call options by funds: $167K | Put options by funds: $21K
1.45% more ownership
Funds ownership: 18.87% → 20.31% (+1.4%)
0% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 9
1% less capital invested
Capital invested by funds: $15.2M → $14.9M (-$220K)
9% less funds holding
Funds holding: 32 → 29 (-3)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$604K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$589K |
| 3 |
SC
Shay Capital
New York
|
+$200K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$151K |
| 5 |
PVI
Pura Vida Investments
New York
|
+$128K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$439K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$327K |
| 3 |
Two Sigma Investments
New York
|
-$158K |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$111K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$93K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NFSG
26
Newbridge Financial Services Group
Boca Raton,
Florida
| $2K | – | – | – |
|
27
Simplex Trading
Chicago,
Illinois
| $2K | +$2.68K | +341 | New |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| $1K | -$9.3K | -1,184 | -92% |
|
29
UBS Group
Zurich,
Switzerland
| $1K | – | – | – |
|
|
GCP
30
GSA Capital Partners
London,
United Kingdom
| – | -$327K | -38,491 | Closed |
|
|
31
Two Sigma Investments
New York
| – | -$158K | -18,532 | Closed |
|
|
ASN
32
Advisory Services Network
Atlanta,
Georgia
| – | -$111K | -13,000 | Closed |
|
|
33
Dimensional Fund Advisors
Austin,
Texas
| – | -$93K | -10,962 | Closed |
|
|
VF
34
Virtu Financial
New York
| – | -$85K | -10,039 | Closed |
|
|
GGI
35
Godsey & Gibb Inc
Richmond,
Virginia
| – | -$4K | -453 | Closed |
|
ACHV Hedge Fund Activity: Q4 2021 in Review
29 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q4 2021, worth a combined $14.9M — down 1.5% from $15.2M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of ACHV and 4 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 9 added.
The largest buyer was Vanguard Group, adding an estimated $604K. The largest seller was Morgan Stanley, cutting an estimated $439K.
- 29 institutional investors held Achieve Life Sciences (ACHV) as of Q4 2021, down from 32 in Q3 2021.
- Funds reported $14.9M of Achieve Life Sciences stock for Q4 2021, down 1.5% quarter-over-quarter.
- 4 funds opened new Achieve Life Sciences positions in Q4 2021 and 7 closed out, a net change of -3 holders.
- The largest Achieve Life Sciences buyer in Q4 2021 was Vanguard Group, an estimated $604K added.
- The largest Achieve Life Sciences seller in Q4 2021 was Morgan Stanley, an estimated $439K sold.
Based on aggregated 13F filings for Q4 2021.